Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IMO the examiner must now take into consideration the re-cert 336 and issue an
Reply New Message
Prev Message Back To Forum Threaded View Next Message

This would be a good time for the company to issue a PR with a legal statement that would clarify possible USPTO pending actions of the reexam based on the recertification. Through the PTSC legal team, the management should issue their legal opinion. This would be something that would benefit all shareholders.

6 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply